Description: Ronald Fawthrop and Brian Holland of the SOA’s Individual Life Experience Committee provided a preview of an upcoming individual life mortality study at the SOA’s Life and Annuity Symposium on May 9, 2017. Their presentations are available here.

Description: "How long is long in longevity? – Jesús-Adrian Álvarez, Ph.D. - Danish Labour Market Supplementary Pension Fund (ATP), The Rate of Aging in humans is constant. New evidence – Marcus Ebeling, PhD., Research Group Mathematical and Actuarial Demography, Max Planck Institute for Demographic Research, Rostock, Germany, Department of Sociology and Demography, University of Rostock, Rostock, Germany; Roland Rau, Ph.D., Professor, Research Group Mathematical and Actuarial Demography, Max Planck Institute for Demographic Research, Rostock, Germany, C6 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Håkan Malmström, Ph.D., C6 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden; Anders Ahlbom, Ph.D., Professor Emeritus, Karen Modig, Ph.D., Associate Professor, C6 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden Human Lifetimes: Finite But Not Necessarily Bounded – Fei Huang, PhD., School of Risk & Actuarial Studies, UNSW Sydney; Ross Maller, Ph.D., Emeritus Professor, Xu Ning, Ph.D., Research School of Finance, Actuarial Studies & Statistics, Australian National University, Brandon Milholland, Ph.D., IQVIA Plymouth Meeting, PA."

Description: "Minimum Social Security Benefit (s) and the Alone Stage of Retirement in the U.S.? – Lori J. Curtis, PhD., Douglas Andrews, FSA, FCIA, Ph.D., University of Waterloo The Importance of Cognitive Health – Gordon Woo,Ph.D., RMS LifeRisks"

Description: Guaranteed Issue mortality valuation tables, report, and definition.

Description: The most recent U.S. population data released by the Centers for Disease Control and Prevention (CDC) and from the U.S. Census at year-end 2021 includes the first ten months of the COVID-19 pandemic in the U.S. While we know the pandemic has had significant impacts on both the U.S. population and insured population mortality, we also see increased mortality due to many other non-COVID causes of death. Where are the biggest changes and what does this non-COVID excess mortality mean over the next few years? Take part as an expert panel hosts an interactive discussion to examine data from general population as well as from both individual life and group life experience studies to explore how these changes might spur innovation in underwriting, assumption setting and pricing.

Description: This report covering the intercompany experience under standard Ordinary insurance issues between 1952 and 1953 anniversaries.

Description: This covers the intercompany mortality experience under Standard Ordinary insurance issues between 1975 and 1976 policy anniversaries, and also for the period between 1971 and 1976 policy anniversaries where one year's exposure generally provided an insufficient volume of data.

Description: This report describes the results of an investigation of the mortality and lapse experience of life insurance policies issued as conversions from Group Life.

Description: This is a discussion about various underwriting issues including broadening the standard class at younger ages, overinsurance, mortality experience on guaranteed and automatic issue and taking smoking habits into account in underwriting life insurance risks. From Transactions of Society of Actuaries 1962, Vol. 14 Pt. 2

Description: A set of mortality improvement factors for year-end 2016 to be used in conjunction with the 2008 VBT or the 2015 VBT for AG-38 purposes.